BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zekri ARN, El Deeb S, Bahnassy AA, Badr AM, Abdellateif MS, Esmat G, Salama H, Mohanad M, El-dien AE, Rabah S, Abd Elkader A. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions. World J Gastroenterol 2018; 24(11): 1228-1238 [PMID: 29568203 DOI: 10.3748/wjg.v24.i11.1228]
URL: https://www.wjgnet.com/1007-9327/full/v24/i11/1228.htm
Number Citing Articles
1
Yue Shi, Xiaoping Men, Xueting Li, Zhicun Yang, Hongjuan Wen. Research progress and clinical prospect of immunocytotherapy for the treatment of hepatocellular carcinomaInternational Immunopharmacology 2020; 82: 106351 doi: 10.1016/j.intimp.2020.106351
2
Jibing Liu, Shuwen Kuang, Yiling Zheng, Mei Liu, Liming Wang. Prognostic and predictive significance of the tumor microenvironment in hepatocellular carcinomaCancer Biomarkers 2021; 32(1): 99 doi: 10.3233/CBM-203003
3
Betul Gok Yavuz, Roberto Carmagnani Pestana, Yehia I. Abugabal, Sunil Krishnan, Jian Chen, Manal M. Hassan, Robert A. Wolff, Asif Rashid, Hesham M. Amin, Ahmed O. Kaseb. Origin and role of hepatic myofibroblasts in hepatocellular carcinomaOncotarget 2020; 11(13): 1186 doi: 10.18632/oncotarget.27532
4
Cunqing Kong, Miao Chen, Xiaohui Fan, Xingcai Chen. Associations between hepatocellular carcinoma risk and rs3212227 and rs568408 polymorphisms: a systematic review and meta-analysisJournal of International Medical Research 2020; 48(8): 030006052094342 doi: 10.1177/0300060520943420
5
Hongda Ding, Junpeng Liu, Baiming Liu, Yongchao Zeng, Pengrui Chen, Yang Su. Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1Biochemical and Biophysical Research Communications 2018; 500(4): 973 doi: 10.1016/j.bbrc.2018.04.219
6
Nathaniel R. Wilson, Laura Bover, Marina Konopleva, Lina Han, Sattva Neelapu, Naveen Pemmaraju. CD303 (BDCA-2) – a potential novel target for therapy in hematologic malignanciesLeukemia & Lymphoma 2021; : 1 doi: 10.1080/10428194.2021.1975192
7
Taqveema Ali, Roli Saxena, Isha Rani, Renuka Sharma, Deepti More, Rajendra Ola, Stuti Agarwal, Yogesh Kumar Chawla, Jyotdeep Kaur. Association of interleukin-18 genotypes (−607C > A) and (−137 G > C) with the hepatitis B virus disease progression to hepatocellular carcinomaMolecular and Cellular Biochemistry 2021; 476(11): 3923 doi: 10.1007/s11010-021-04206-1
8
Jian Wang, Cun-Di Li, Lin Sun. Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular CarcinomaBiomolecules 2020; 10(2): 301 doi: 10.3390/biom10020301
9
Takahiro Kodama, Tetsuo Takehara. Liver Immunology2020; : 505 doi: 10.1007/978-3-030-51709-0_31
10
So Mee Kwon, Anuradha Budhu, Hyun Goo Woo, Jittiporn Chaisaingmongkol, Hien Dang, Marshonna Forgues, Curtis C. Harris, Gao Zhang, Noam Auslander, Eytan Ruppin, Chulabhorn Mahidol, Mathuros Ruchirawat, Xin Wei Wang. Functional Genomic Complexity Defines Intratumor Heterogeneity and Tumor Aggressiveness in Liver CancerScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52578-8